University at Albany Cancer Research Center (CRC) post-doctoral associate, Dr. Rebecca Sinnott DeVaux, has been awarded a $505,659 highly competitive “Breakthrough Award” from the U.S. Department of Defense’s Breast Cancer Research Program (one of 15 awarded from 321 proposals) to study an enigmatic RNA gene as a tool to distinguish aggressive from indolent breast cancers and identify why some breast cancers become life-threatening metastasis. Her findings, she said, could greatly lessen the degree of overtreatment of breast cancer. Dr. DeVaux works in the lab of Dr. Jason Herschkowitz, assistant professor of Biomedical Sciences at the University at Albany School of Public Health. “The results of Dr. DeVaux’s cutting edge research will have an impact on the clinical care of breast cancer patients diagnosed with very early stage disease in the near future and on the treatment of more advanced breast cancer later on,” said Dr. Martin Tenniswood, CRC director and Empire Innovations Professor of biomedical sciences in the School of Public Health. Click here to learn more about Dr. DeVaux’s research.